Skip to main content

SALL3 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83490

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-83490-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of human SALL3. Peptide sequence: MSRRKQAKPQHLKSDEELLPPDGAPEHAAPGEGAEDADSGPESRSGGEET The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for SALL3 Antibody

Western Blot: SALL3 Antibody [NBP2-83490]

Western Blot: SALL3 Antibody [NBP2-83490]

Western Blot: SALL3 Antibody [NBP2-83490] - Host: Rabbit. Target Name: SALL3. Sample Tissue: Human A549 Whole Cell lysates. Antibody Dilution: 1ug/ml

Applications for SALL3 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: SALL3

Probable transcription factor

Alternate Names

C2H2 zinc finger protein SALL3, hSALL3, sal-like 3 (Drosophila), spalt-like zinc finger protein, ZNF796

Gene Symbol

SALL3

Additional SALL3 Products

Product Documents for SALL3 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SALL3 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...